Ipamorelin vs Sermorelin

Reviewed by Gabriel Brocklesby · Last updated

Both appear in hormone optimisation and longevity clinic listings as GH secretagogue options. Compare provider transparency and monitoring protocols.

Ipamorelin and sermorelin are commonly referenced in clinic protocols aimed at hormone optimisation. Use this comparison to assess how providers explain rationale, eligibility, and monitoring.

Ipamorelin

A GH secretagogue referenced in longevity and performance listings, typically injectable.

Potential benefits

  • Often listed in GH-support protocols.
  • Common in longevity clinic menus.

Considerations

  • Human evidence remains limited.
  • Monitoring practices differ across clinics.
Best for: Comparing clinics that list GH secretagogue protocols.

Sermorelin

A growth hormone–releasing hormone analogue used in hormone optimisation contexts.

Potential benefits

  • Common in longevity and hormone optimisation listings.
  • Often paired with other secretagogues.

Considerations

  • Evidence base varies by provider.
  • Requires clinical assessment.
Best for: Evaluating clinics with structured hormone programmes.
CategoryIpamorelinSermorelin
Directory contextInformational clinic and treatment comparison context.Informational clinic and treatment comparison context.
Common goalsCompare how clinics frame suitability, monitoring, and expected use cases.Compare how clinics frame suitability, monitoring, and expected use cases.
Guidance noteInformational listing only; suitability requires clinician review.Informational listing only; suitability requires clinician review.

Next step

Compare clinics offering these treatments

Use city pages and peptide-specific pages to move from general research into actual provider shortlists. That usually gives a better buying picture than comparing drug names alone.

Related clinics

FeaturedVerified

Menon Health

London, United Kingdom

Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.

In personRemoteFrom £195Virtual consultations
View ProfileSend EnquiryCompare

Conclusion

These are usually offered by similar clinics. Choose based on provider quality and monitoring standards rather than the peptide label.

Related peptide pages

London treatment pages

US city pages

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.